These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4043206)

  • 1. Demonstration of specific binding sites for [3H]mazindol in rat hypothalamus: correlation with the anorectic properties of phenylethylamines.
    Angel I; Paul SM
    Eur J Pharmacol; 1985 Jul; 113(1):133-4. PubMed ID: 4043206
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of [3H]mazindol binding in rat brain: sodium-sensitive binding correlates with the anorectic potencies of phenylethylamines.
    Angel I; Luu MD; Paul SM
    J Neurochem; 1987 Feb; 48(2):491-7. PubMed ID: 3467029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anorectic activities of serotonin uptake inhibitors: correlation with their potencies at inhibiting serotonin uptake in vivo and 3H-mazindol binding in vitro.
    Angel I; Taranger MA; Claustre Y; Scatton B; Langer SZ
    Life Sci; 1988; 43(8):651-8. PubMed ID: 3261828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of serotonergic and dopaminergic lesions on sodium-sensitive [3H]mazindol binding in rat hypothalamus and corpus striatum.
    Angel I; Janowsky A; Paul SM
    Brain Res; 1989 Dec; 503(2):339-41. PubMed ID: 2514010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between anorectic potency and affinity for hypothalamic (+)-amphetamine binding sites of phenylethylamines.
    Blosser JC; Barrantes M; Parker RB
    Eur J Pharmacol; 1987 Jan; 134(1):97-103. PubMed ID: 3556402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location and effect of obesity on putative anorectic binding sites in the rat brain.
    Dunn-Meynell AA; Levin BE
    Obes Res; 1997 May; 5(3):201-7. PubMed ID: 9192394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling between hypothalamic alpha 2-adrenoceptors and [3H]mazindol binding site in response to several hyperglycaemic stimuli in mice.
    Angel I; Taranger MA
    Brain Res; 1989 Jun; 490(2):367-72. PubMed ID: 2548657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of [3H]mazindol binding to subhypothalamic areas: involvement in glucoprivic feeding.
    Angel I; Kiss A; Stivers JA; Skirboll L; Crawley JN; Paul SM
    Brain Res Bull; 1986 Dec; 17(6):873-7. PubMed ID: 3801941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs; an experimental study in the isolated perfused rat lung, II. Fenfluramine, mazindol, mefenorex, phentermine and R 800.
    Seiler KU; Wassermann O; Wensky H
    Clin Exp Pharmacol Physiol; 1976; 3(4):323-30. PubMed ID: 975621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low affinity hypothalamic [3H]mazindol binding: a probe for hypothalamic body weight regulation?
    Gleiter CH; Linnoila M; Nutt DJ
    Appetite; 1989 Apr; 12(2):137-43. PubMed ID: 2764554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices.
    Heikkila RE; Cabbat FS; Mytilineou C
    Eur J Pharmacol; 1977 Oct; 45(4):329-33. PubMed ID: 923643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the site of action of a new anorectic agent, fenfluramine.
    Foxwell MH; Funderburk WH; Ward JW
    J Pharmacol Exp Ther; 1969 Jan; 165(1):60-70. PubMed ID: 5782834
    [No Abstract]   [Full Text] [Related]  

  • 13. (+)-Amphetamine binding to rat hypothalamus: relation to anorexic potency for phenylethylamines.
    Paul SM; Hulihan-Giblin B; Skolnick P
    Science; 1982 Oct; 218(4571):487-90. PubMed ID: 7123250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies with several analogs of mazindol: correlation between effects on dopamine uptake and various in vivo responses.
    Heikkila RE; Babington RG; Houlihan WJ
    Eur J Pharmacol; 1981 May; 71(2-3):277-86. PubMed ID: 7250190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological action of mazindol on behaviors and metabolism].
    Nagai K; Mori T; Ookura M; Tsujimoto H; Nakagawa H
    Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):133-45. PubMed ID: 6745804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased potency and binding of mazindol to putative brain anorectic receptors in obesity-prone rats.
    Levin BE; Brown KL; Vincent G
    Brain Res; 1994 Dec; 668(1-2):171-9. PubMed ID: 7704603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1988 Apr; 245(1):199-210. PubMed ID: 3129549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes.
    Javitch JA; Blaustein RO; Snyder SH
    Eur J Pharmacol; 1983 Jun; 90(4):461-2. PubMed ID: 6884434
    [No Abstract]   [Full Text] [Related]  

  • 19. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the non-amphetaminergic anorexiant, mazindol, on neuronal activity and hypothalamic control of gastric acid secretion in rats.
    Shiraishi T
    Int J Obes; 1985; 9(4):285-97. PubMed ID: 3905642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.